about
Whole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studiesPrimary Breast Lymphoma in a Woman: A Case Report and Review of the LiteraturePrimary cardiac lymphoma with unusual presentation: A report of two cases.Primary Orbital Follicular Lymphoma: A Case Report and Review.Usefulness of (18)F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Patients with High-Grade Non-Hodgkin's Lymphoma.On the added value of baseline FDG-PET in malignant lymphoma.The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public HospitalSalvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin's lymphoma patients with a poor performance status or comorbidity.FDG-PET/CT in lymphoma.Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapyDoes the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma.Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairsRadiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma.Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patientsDoes Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted ImagingPatients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma.Considerations in the initial management of follicular lymphoma.Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient settingF-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow InvolvementHepatitis viruses and non-Hodgkin's lymphoma: A reviewFDG-PET imaging in hematological malignanciesClinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma.Whole-body diffusion-weighted imaging for staging malignant lymphoma in children.Primary esophageal lymphoma in immunocompetent patients: Two case reports and literature review.Magnetic resonance imaging of malignant lymphoma.Primary lymphoma of the uterus and cervix: two case reports and review of the literature.Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.Cervical lymphadenopathy: Unwinding the hidden truth.Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis.Sinonasal natural killer/T-cell lymphoma presenting as pyrexia of unknown origin with nasal symptoms.Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis.Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study.
P2860
Q27009307-05FBEB35-E953-4815-9BBE-5559CD64AA38Q28078192-EBBF3660-13A3-4804-BF4F-FC32D9332F02Q33599078-D26BB8A2-403C-4547-B242-5B7F3F639636Q33666966-919F5A44-F1CB-4DDE-A822-661A9F5E17EDQ33704669-3FD75B2A-1F84-45A8-8AEC-8AAFE6B4D7A5Q33749537-317F1C65-B8F7-419A-AA0C-37CA09995D08Q33752272-989C95C7-940D-412A-BD2F-15FBCC51409AQ33859497-41BAFBE4-116F-4F2B-A78A-E97F94990FF4Q34293322-F5388EBB-3D21-4538-9818-AA2810390877Q34408847-E9255EF9-E498-4D12-B800-7A67D8C2FB10Q34451400-A2253C62-C3C9-4E5E-97E0-121BC37CDA68Q35187833-5C95C060-E5B9-429D-A40F-E58D74EA610EQ35524728-856DEC98-68B7-4A43-AF05-BF8296C6FB16Q36003601-599AB017-7B60-45B1-A352-92A046CC640CQ36138213-4F501305-2349-42A2-9DA7-517EEE78866FQ36162589-DD261B5D-88FE-463E-9B87-BC10EF7F812FQ36435559-ACA271B7-03BA-4730-89B4-042998CD8272Q36564214-B79675AF-DBD4-4BA6-AB23-2912031D2B53Q36676040-C238E6A7-39B9-4F1F-81AE-E28894903D83Q36724776-E8AA71EB-4B04-460B-912C-4613A8974F57Q36741541-815C88FE-5A1F-450C-91C8-D2B0F2CAE1A9Q36911500-3C738790-F190-4393-A2CF-289D7E69FB7AQ36911505-EE36A51F-D46F-45D1-B60E-556AA949FC08Q37011126-3F3DE3A3-3302-4251-878D-C30FB5A1F230Q37195543-6C8B24BE-E76D-458F-AE57-7C66526719EAQ37632114-012DC318-8D47-45CB-ACB7-D98B73AD9C0FQ37683257-6E0573CD-AE0E-48F3-9FA8-B2D93FD3E9FCQ37777048-35769E7A-F622-47AD-82C8-71EEB49AA213Q37821252-5815E52C-F972-47A9-A8CE-A04B3DDC96C4Q37865544-E6E7FCC5-CA38-49D7-930A-684E00A6F1D0Q37933459-EC935C6D-E2CF-4986-A1D7-B3ED81E4C2EFQ38831143-64713A7C-9965-488B-BD36-DD6126DFC576Q38948399-0749AA0C-0911-4069-8BE5-C831AF4C8EEEQ39030042-0E4DD7D2-9DE0-4961-AB35-D76D10A10029Q39134477-428C4FA4-C06F-44F8-953C-0EF9A577AF0BQ40276297-D22FCC22-18D8-4E60-9FB0-6917247285EAQ40725508-38AAEEC8-436A-4E97-80BC-34922A9C2118Q41982990-9A37E253-8E6E-4A2E-BB81-1BF7FAB05C60Q41996096-BB33F8F4-9E6B-4836-B477-E73980F67DB7Q43941770-A0045C63-A348-43BF-B4EE-3360D1C29FA4
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Staging non-Hodgkin lymphoma.
@ast
Staging non-Hodgkin lymphoma.
@en
type
label
Staging non-Hodgkin lymphoma.
@ast
Staging non-Hodgkin lymphoma.
@en
prefLabel
Staging non-Hodgkin lymphoma.
@ast
Staging non-Hodgkin lymphoma.
@en
P1433
P1476
Staging non-Hodgkin lymphoma.
@en
P304
P356
10.3322/CANJCLIN.55.6.368
P407
P577
2005-11-01T00:00:00Z